Check out an interview with our CEO, Chris Savile, where he provides some additional information on our Q2 results and outlook for the rest of 2024.
youtu.be/SLZNYorJN_0?si=hAYF…
Please see our Q2 2024 financial results and corporate update.
willowbio.com/willow-bioscie…
We're excited to announce another new, large partnership that extends our technology platform to the production of biopesticides. This partnership brings both significant near-term R&D revenue and long-term upside.
willowbio.com/willow-bioscie…
Sorry, we're a bit behind on our posts. If you haven't read it yet, here's the recent PR announcing our large partnership with Laurus Labs.
willowbio.com/willow-announc…
Check out our 2022 recap and 2023 outlook.
willowbio.com/press-releases…
Check out our most recent press release providing an update on our business and operations.
willowbio.com/press-releases…
@WillowBio is very pleased to announce the signing of a Master Service Agreement with @KalsecInc for the development and manufacture of functional food ingredients, using the FutureGrown precision fermentation platform.
prnewswire.com/news-releases…
Join @WillowBio at 2pm EST on Thursday, November 10th for an Investor Presentation Webcast, and live Q&A session.
willowbio.com/press-releases…
@WillowBio is pleased to announce Q3 results, and the appointment of Dr. Peter Seufer-Wasserthal as President and CEO.
willowbio.com/press-releases…
@willowbio announces the addition of a new pure, consistent and sustainable functional ingredient; FutureGrown Astaxanthin. This carotenoid is used in animal feed as a pigment, and in cosmetics & nutraceuticals for its powerful antioxidant properties.
prnewswire.com/news-releases…
Biden’s executive order advancing biotech signals a promising future for the industry. At Willow, we have been working towards providing pure, consistent & sustainable functional ingredients since 2019, and we are proud to be a part of the Bio Revolution.
whitehouse.gov/briefing-room…
Check out our recent press release providing an update on CBG including manufacturing, safety and IP
willowbio.com/press-releases…
Willow Biosciences completes Q2 with significant progress to its operational platform, leadership and liquidity. Read more in our press release.
#FutureGrown #SynBio #Biosynthesis
prnewswire.com/news-releases…
Next week, Willow is attending IFT first, the premier B2B #foodtech expo in Chicago. Looking forward to discussing functional ingredients and Willow's own sustainable #FutureGrown platform.
#biotech #natural #SynBio
Willow has incorporated Inscripta's Onyx Genome Engineering Platform into its strain engineering workflows. Read more in our press release here.
#FutureGrown #SynBio
prnewswire.com/news-releases…
Willow expands its portfolio with a new partnered pharmaceutical project demonstrating the wide array of opportunities accessible to Willow’s #FutureGrown technology platform.
willowbio.com/press-releases…
Willow Biosciences, Inc. retweeted
$WLLW Willow Biosciences strikes manufacturing partnership to boost production capacity for its cannabinoid products tinyurl.com/y3xannv4 @WillowBio $CANSF #WLLW #CANSF
Check out our recent press release announcing our expanding fermentation network and progress on our #FutureGrown CBG GRAS determination
willowbio.com/press-releases…
Come visit us at New York Society of Cosmetic Chemists Supplier’s Day, May 3-4 in New York City’s Javits Convention Center – booth 459
nysuppliers22.mapyourshow.co…
Fresh from a great show at In-Cosmetics Paris, Willow is going to be exhibiting at The CBD Show in London on Apr 22-23.
Come see our own Dr. Simon Hickling giving a talk on Willow's #FutureGrown fermentation technology platform on Saturday's seminar agenda.





